Epigenetics Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027

The global epigenetics market was valued at $772 million in 2019 and is projected to reach $2,168 million by 2027, registering a CAGR of 13% from 2021 to 2027. 

Epigenetic genetics is the study of heritable changes in gene function that do not include changes in DNA sequence, such as changes in chromosomes, phenotypes that affect gene activity and expression. The causes of heritable changes can be environmental factors or external factors of internal factors such as age, disease, and others. Examples of epigenetics are DNA methylation and histone modifications, which alter gene expression without altering the DNA sequence.

Market Segments

By Type

• Kits
• Reagents
• Enzymes
• Instruments
• Others

By Application

• Oncology
• Non-oncology

By End User

• Academic and Research Institutes
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations (CROs)

Key Players

• Merck KGaA
• Thermo Fisher Scientific Inc.
• ABCAM Plc
• Agilent Technologies
• Active Motif
• Qiagen
• Bio-Rad Laboratories, Inc.
• Perkinelmer Inc.

Scope of the Report

The research study analyzes the global Epigenetics industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Epigenetics Market Report

1. What was the Epigenetics Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027). 2. What will be the CAGR of the Epigenetics Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Epigenetics Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.